@taylorstjames
I disagree that Remestemcel-L has been validated by big pharma.
The only thing that can bring about a validation of Remestemcel-L is a great result in the Phase III readout, which is yet to be revealed.
Until then it remains completely unvalidated...
@taylorstjamesI disagree that Remestemcel-L has been validated...
-
- There are more pages in this discussion • 2,170 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.035(3.57%) |
Mkt cap ! $1.167B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $2.235M | 2.193M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 100168 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 58297 | 17 |
View Market Depth
| Last trade - 11.30am 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |